Since December 2019, the ongoing coronavirus disease 2019 (COVID-19) pandemic has significantly affected solid organ transplantation (SOT) worldwide and has become a threat to the lives of SOT recipients. Here, we have reviewed, condensed, and organized the available information on COVID-19 to provide recommendations to transplant healthcare workers. Our review of reported cases shows that the symptoms of SOT patients with COVID-19 are similar to those of the normal population, but their severity and outcomes are worse. Thus far, there is no evidence that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly causes permanent damage to kidney, liver, or heart allografts.
All Keywords
【저자키워드】 COVID-19, Clinical characteristics, solid organ transplantation, Immunosuppressant, transplant safety, 【초록키워드】 coronavirus disease, SARS-CoV-2, coronavirus, pandemic, severity, Symptom, outcome, kidney, healthcare, information, liver, Evidence, SOT, acute respiratory syndrome, recipients, recommendation, affected, significantly, reported, cause, organized, SOT patient, with COVID-19, 【제목키워드】 transplantation, Solid,
【저자키워드】 COVID-19, Clinical characteristics, solid organ transplantation, Immunosuppressant, transplant safety, 【초록키워드】 coronavirus disease, SARS-CoV-2, coronavirus, pandemic, severity, Symptom, outcome, kidney, healthcare, information, liver, Evidence, SOT, acute respiratory syndrome, recipients, recommendation, affected, significantly, reported, cause, organized, SOT patient, with COVID-19, 【제목키워드】 transplantation, Solid,